J&J drops stem cell partner Capricor – BioPharma Dive
|
J&J drops stem cell partner Capricor
BioPharma Dive In a move resulting in an almost 10% dive of the smaller company's share price, Johnson & Johnson has dumped its stem cell partner Capricor Therapeutics, deciding not to exercise its option for Capricor's lead allogeneic cell-based product candidate … |
